TY  - JOUR
AU  - Ferreira, Vitor
AU  - Folgueira, Cintia
AU  - García-Altares, María
AU  - Guillén, Maria
AU  - Ruíz-Rosario, Mónica
AU  - DiNunzio, Giada
AU  - Garcia-Martinez, Irma
AU  - Alen, Rosa
AU  - Bookmeyer, Christoph
AU  - Jones, John G
AU  - Cigudosa, Juan C
AU  - López-Larrubia, Pilar
AU  - Correig-Blanchar, Xavier
AU  - Davis, Roger J
AU  - Sabio, Guadalupe
AU  - Rada, Patricia
AU  - Valverde, Ángela M
PY  - 2023
DO  - 10.1016/j.redox.2023.102741
UR  - http://hdl.handle.net/20.500.12105/16420
AB  - Olanzapine (OLA), a widely used second-generation antipsychotic (SGA), causes weight gain and metabolic alterations when administered orally to patients. Recently, we demonstrated that, contrarily to the oral treatment which induces weight gain, OLA...
LA  - eng
PB  - Elsevier
KW  - Signal Transduction
KW  - Fatty Liver
KW  - Male
KW  - Animals
KW  - Mice
KW  - Olanzapine
KW  - Protein Tyrosine Phosphatase, Non-Receptor Type 1
KW  - AMP-Activated Protein Kinases
KW  - Liver
KW  - Mice, Knockout
KW  - Inflammation
KW  - Fatty Acid Synthases
KW  - Weight Gain
KW  - Hypothalamus
KW  - Mice, Inbred C57BL
TI  - Hypothalamic JNK1-hepatic fatty acid synthase axis mediates a metabolic rewiring that prevents hepatic steatosis in male mice treated with olanzapine via intraperitoneal: Additional effects of PTP1B inhibition.
TY  - journal article
ER  -